{{Rsnum
|rsid=2420371
|Gene=F5
|Chromosome=1
|position=169522317
|Orientation=plus
|GMAF=0.0303
|Gene_s=F5
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 88.4 | 10.7 | 0.9
| HCB | 100.0 | 0.0 | 0.0
| JPT | 100.0 | 0.0 | 0.0
| YRI | 100.0 | 0.0 | 0.0
| ASW | 98.2 | 1.8 | 0.0
| CHB | 100.0 | 0.0 | 0.0
| CHD | 99.1 | 0.9 | 0.0
| GIH | 82.2 | 16.8 | 1.0
| LWK | 99.1 | 0.9 | 0.0
| MEX | 93.1 | 5.2 | 1.7
| MKK | 94.8 | 5.2 | 0.0
| TSI | 81.4 | 18.6 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22443383
|Trait=None
|Title=Genome wide association study for plasma levels of natural anticoagulant inhibitors and protein C anticoagulant pathway: the MARTHA project.
|RiskAllele=G
|Pval=4E-80
|OR=1.1600
|ORtxt=None
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}